32 results:
11. Clinical efficacy in TBI  
Clinical efficacy and patient benefits Several clinical pilot trials have been performed using Cerebrolysin in traumatic brain injury. Cerebrolysin was administered as an adjunctive…  
12. Expert Interviews  
Expert InterviewsInterview with Chief Investigator of Captain We asked the CAPTAIN key investigator Prof. Dafin Muresanu for an interview and discussed with him some topics like dosage regime of…  
13. Download materials stroke  
Download area - Stroke This page includes some information that is intended for registered useres only. If you would like to access this information please login.> General Cerebrolysin…  
14. About Cerebrolysin  
About Cerebrolysin Cerebrolysin is a multi-modal neuropeptide drug with a fast onset of action that helps to regain and maintain the independence of patients suffering from stroke, TBI, dementia and…  
15. 404  
Site not found - 404 Error The site you requested was not found. Please check the URL to ensure that the path is correct.  
16. Download materials dementia  
Download area - Dementia> General Cerebrolysin Information  
17. Terms of Use  
Terms of Use Last updated: 11.04.2018 1. Scope of Agreement 1.1. The use of the services on the non-public product sites on www.cerebrolysin.com ("Website") is offered to you by EVER Neuro…  
18. Disclaimer  
Disclaimer EVER Pharma undertakes all appropriate effort to make correct and complete information available on this website, but assumes no responsibility, guarantees or liability whatsoever that…  
19. Adverse Events  
Dr. Barbara KDownload In case of emergencies please dial: Tel.: +43 7665 20 555 - 0  
20. Contact EVER Pharma  
Contact EVER PharmaEVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria Phone: +43 7665 20555 0 Fax: +43 7665 20555 910 E-Mail: office(at)everpharma.com www.everpharma.com  

Search results 11 until 20 of 32